Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
$378M |
| 2 |
AT&T
T
|
$328M |
| 3 |
Roku
ROKU
|
$326M |
| 4 |
Qualcomm
QCOM
|
$269M |
| 5 |
PARA
Paramount Global Class B
PARA
|
$255M |
Top Sells
| 1 |
Baidu
BIDU
|
$1.17B |
| 2 |
Bristol-Myers Squibb
BMY
|
$727M |
| 3 |
Pinduoduo
PDD
|
$599M |
| 4 |
AbbVie
ABBV
|
$564M |
| 5 |
Chipotle Mexican Grill
CMG
|
$483M |
Sector Composition
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 10.61% |
| 5 | Consumer Staples | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$251B
| $1.68B | 2.08% | 24,846,671 -1,994,500 | -7% | -$134M |
|
2
VeriSign
VRSN
$25.5B
| $968M | 1.2% | 4,868,314 -853,220 | -15% | -$170M |
|
3
Zoom
ZM
$24.4B
| $810M | 1.01% | 2,520,863 +132,329 | +6% | +$42.5M |
|
4
Monster Beverage
MNST
$60.9B
| $725M | 0.9% | 7,956,760 -2,272,900 | -22% | -$207M |
|
5
Target
TGT
$43.6B
| $710M | 0.88% | 3,586,059 -1,759,606 | -33% | -$349M |
|
6
Atlassian
TEAM
$46.6B
| $704M | 0.88% | 3,341,420 -1,003,600 | -23% | -$212M |
|
|
7
Baidu
BIDU
$32.8B
| $697M | 0.87% | 3,204,791 -5,385,073 | -63% | -$1.17B |
|
8
Palo Alto Networks
PANW
$127B
| $664M | 0.83% | 2,063,130 -989,599 | -32% | -$319M |
|
9
Kroger
KR
$44.9B
| $618M | 0.77% | 17,174,071 -7,473,144 | -30% | -$269M |
|
10
Franco-Nevada
FNV
$36.3B
| $606M | 0.75% | 4,837,390 -705,200 | -13% | -$88.4M |
|
11
Vodafone
VOD
$28.8B
| $595M | 0.74% | 32,310,076 -4,672,900 | -13% | -$86.1M |
|
12
Molina Healthcare
MOH
$9.8B
| $577M | 0.72% | 2,466,415 -633,950 | -20% | -$148M |
|
|
ABMD
13
DELISTED
Abiomed Inc
ABMD
| $567M | 0.71% | 1,780,123 -213,677 | -11% | -$68.1M |
|
|
14
Tesla
TSLA
$1.08T
| $553M | 0.69% | 827,381 +566,506 | +217% | +$378M |
|
15
Biogen
BIIB
$19.4B
| $542M | 0.67% | 1,938,162 -1,099,600 | -36% | -$308M |
|
16
United Therapeutics
UTHR
$13.8B
| $537M | 0.67% | 3,207,591 -399,700 | -11% | -$66.9M |
|
17
Hershey
HSY
$37.3B
| $532M | 0.66% | 3,361,261 -20,005 | -0.6% | -$3.16M |
|
18
Vertex Pharmaceuticals
VRTX
$100B
| $516M | 0.64% | 2,400,284 -1,175,646 | -33% | -$253M |
|
|
ALXN
19
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $509M | 0.63% | 3,328,121 -785,583 | -19% | -$120M |
|
20
F5
FFIV
$18B
| $500M | 0.62% | 2,397,136 -621,700 | -21% | -$130M |
|
|
HZNP
21
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $480M | 0.6% | 5,209,963 -1,589,000 | -23% | -$146M |
|
|
22
Roku
ROKU
$14.2B
| $474M | 0.59% | 1,455,700 +1,001,745 | +221% | +$326M |
|
23
Etsy
ETSY
$5.25B
| $465M | 0.58% | 2,308,208 -1,521,900 | -40% | -$307M |
|
24
Fortinet
FTNT
$60.4B
| $447M | 0.56% | 2,424,684 -1,115,800 | -32% | -$206M |
|
25
Alphabet (Google) Class A
GOOGL
$2.57T
| $442M | 0.55% | 214,348 +22,400 | +12% | +$46.2M |
|